The Fiducian Technology Fund (Fund) invests worldwide in companies at the forefront of technological research and innovation and with potential for significant future earnings growth. As such, it focuses on industries and companies that could eventually transform society, investing in exciting sciences like biotechnology, robotics, artificial intelligence and nano-technology.

The Fund is well diversified, with each of the four underlying investment managers holding between 30 and 100 stocks. It is managed using Fiducian's unique Manage the Manager system, which aims to deliver superior returns with reduced risk.

With no relevant market index comparable to the Fund's technology portfolio, we use the NASDAQ-100 index (currency hedged $AUD) as a proxy, and the Fund's objective is to exceed this index (after fees) over rolling three-year periods.

Investors who are seeking to profit from the potential of new technologies may consider investing in the Fiducian Technology Fund. However, investors must accept that this is a high-risk sector and the Fund may experience periods of high volatility in the short and medium term.